Non-Thermal Plasma As An Innovative Anticancer Strategy On Leukemia Models

Q1 Medicine
Eleonora Turrini , Augusto Stancampiano , Emanuele Simoncelli , Romolo Laurita , Elena Catanzaro , Cinzia Calcabrini , Matteo Gherardi , Vittorio Colombo , Carmela Fimognari
{"title":"Non-Thermal Plasma As An Innovative Anticancer Strategy On Leukemia Models","authors":"Eleonora Turrini ,&nbsp;Augusto Stancampiano ,&nbsp;Emanuele Simoncelli ,&nbsp;Romolo Laurita ,&nbsp;Elena Catanzaro ,&nbsp;Cinzia Calcabrini ,&nbsp;Matteo Gherardi ,&nbsp;Vittorio Colombo ,&nbsp;Carmela Fimognari","doi":"10.1016/j.cpme.2017.12.025","DOIUrl":null,"url":null,"abstract":"<div><p><span><span>Antitumor chemotherapy is often hampered by the low therapeutic index of most anticancer drugs and the development of chemoresistance. Furthermore, in leukemia incidence and death rates </span>in patients<span> are really close to each other, when compared to other kind of tumors; pointing out that efficacy of anticancer therapy<span><span> is suboptimal. Thus, there is a continuous need for new intervention strategies, endowed with a better pharmaco-toxicological profile. Cold atmospheric plasma (CAP) has gained interest as a promising anticancer strategy and earlier studies demonstrated the “non-aggressive” nature of CAP [1]. Several lines of evidence showed that the anticancer activity of CAP mainly depends on the increase in oxidative and nitrosative stress that leads to tumor </span>cell death [2]. However, mechanisms of CAP-cell interaction are not yet completely understood. In this context, the aim of this work is to unravel CAP anticancer effects on </span></span></span><em>in vitro</em> and <span><em>ex vivo</em></span><span><span><span> leukemia models achieved within the Italian national project “Scientific Independence for young Researchers” (SIR), that brings together a multidisciplinary team in the areas of Engineering, Pharmacology and Oncohematology. The cytotoxic impact of different CAP treatments performed by means of two plasma sources, a nanosecond pulsed </span>dielectric<span> barrier discharge (DBD) [3,4] and a microsecond pulsed DBD jet (Fig.1), on T-lymphoblastic cell lines was investigated. In particular, we analyzed apoptotic and/or necrotic events, cell-cycle progression, levels of proteins involved in the regulation of apoptosis correlated to reactive oxygen and nitrogen species (RONS) induced in culture medium by CAP treatment. Due to the key role of RONS in the biological effects of CAPs, its genotoxic potential was assessed. Furthermore, some preliminary results indicate that CAPs can induce cytotoxic effects also on leukemia cells cultivated in </span></span>hypoxia, which plays a critical role in promoting chemoresistance. Taken together, the results we obtained contribute to understand the pharmaco-toxicological potential of CAP, thus making the basis to further investigate its anticancer properties.</span><span><figure><span><img><ol><li><span>Download : <span>Download high-res image (66KB)</span></span></li><li><span>Download : <span>Download full-size image</span></span></li></ol></span></figure></span></p><p>Figure 1: Nanosecond pulsed DBD on a grounded plate (right) and microsecond pulsed DBD jet (left).</p></div>","PeriodicalId":46325,"journal":{"name":"Clinical Plasma Medicine","volume":null,"pages":null},"PeriodicalIF":0.0000,"publicationDate":"2018-02-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://sci-hub-pdf.com/10.1016/j.cpme.2017.12.025","citationCount":"3","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"Clinical Plasma Medicine","FirstCategoryId":"1085","ListUrlMain":"https://www.sciencedirect.com/science/article/pii/S2212816617300501","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"Q1","JCRName":"Medicine","Score":null,"Total":0}
引用次数: 3

Abstract

Antitumor chemotherapy is often hampered by the low therapeutic index of most anticancer drugs and the development of chemoresistance. Furthermore, in leukemia incidence and death rates in patients are really close to each other, when compared to other kind of tumors; pointing out that efficacy of anticancer therapy is suboptimal. Thus, there is a continuous need for new intervention strategies, endowed with a better pharmaco-toxicological profile. Cold atmospheric plasma (CAP) has gained interest as a promising anticancer strategy and earlier studies demonstrated the “non-aggressive” nature of CAP [1]. Several lines of evidence showed that the anticancer activity of CAP mainly depends on the increase in oxidative and nitrosative stress that leads to tumor cell death [2]. However, mechanisms of CAP-cell interaction are not yet completely understood. In this context, the aim of this work is to unravel CAP anticancer effects on in vitro and ex vivo leukemia models achieved within the Italian national project “Scientific Independence for young Researchers” (SIR), that brings together a multidisciplinary team in the areas of Engineering, Pharmacology and Oncohematology. The cytotoxic impact of different CAP treatments performed by means of two plasma sources, a nanosecond pulsed dielectric barrier discharge (DBD) [3,4] and a microsecond pulsed DBD jet (Fig.1), on T-lymphoblastic cell lines was investigated. In particular, we analyzed apoptotic and/or necrotic events, cell-cycle progression, levels of proteins involved in the regulation of apoptosis correlated to reactive oxygen and nitrogen species (RONS) induced in culture medium by CAP treatment. Due to the key role of RONS in the biological effects of CAPs, its genotoxic potential was assessed. Furthermore, some preliminary results indicate that CAPs can induce cytotoxic effects also on leukemia cells cultivated in hypoxia, which plays a critical role in promoting chemoresistance. Taken together, the results we obtained contribute to understand the pharmaco-toxicological potential of CAP, thus making the basis to further investigate its anticancer properties.

  1. Download : Download high-res image (66KB)
  2. Download : Download full-size image

Figure 1: Nanosecond pulsed DBD on a grounded plate (right) and microsecond pulsed DBD jet (left).

非热等离子体作为白血病模型的创新抗癌策略
抗肿瘤化疗往往受到大多数抗癌药物治疗指数低和化疗耐药的发展的阻碍。此外,与其他类型的肿瘤相比,白血病患者的发病率和死亡率非常接近;指出抗癌治疗的效果并不理想。因此,不断需要新的干预策略,赋予更好的药物毒理学概况。冷大气等离子体(CAP)作为一种有前途的抗癌策略已经引起了人们的兴趣,早期的研究证明了CAP[1]的“非侵袭性”。多项证据表明,CAP的抗癌活性主要依赖于导致肿瘤细胞死亡的氧化应激和亚硝化应激的增加。然而,cap -细胞相互作用的机制尚不完全清楚。在这种情况下,这项工作的目的是揭示CAP对体外和离体白血病模型的抗癌作用,该模型是在意大利国家项目“年轻研究人员科学独立”(SIR)中实现的,该项目汇集了工程、药理学和肿瘤血液学领域的多学科团队。研究了纳秒脉冲介质阻挡放电(DBD)[3,4]和微秒脉冲DBD射流(图1)两种等离子体源对不同CAP处理对t淋巴母细胞系的细胞毒性影响。特别地,我们分析了细胞凋亡和/或坏死事件、细胞周期进程、参与细胞凋亡调控的蛋白水平,这些蛋白与CAP处理在培养基中诱导的活性氧和活性氮(RONS)相关。鉴于ron在cap生物效应中的关键作用,我们对其遗传毒性进行了评估。此外,一些初步结果表明,CAPs还能对缺氧培养的白血病细胞产生细胞毒作用,这在促进化疗耐药中起关键作用。综上所述,我们得到的结果有助于了解CAP的药理学潜力,从而为进一步研究其抗癌特性奠定基础。下载:下载高分辨率图片(66KB)下载:下载全尺寸图片图1:接地板上的纳秒脉冲DBD(右)和微秒脉冲DBD射流(左)。
本文章由计算机程序翻译,如有差异,请以英文原文为准。
求助全文
约1分钟内获得全文 求助全文
来源期刊
Clinical Plasma Medicine
Clinical Plasma Medicine MEDICINE, RESEARCH & EXPERIMENTAL-
自引率
0.00%
发文量
0
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
确定
请完成安全验证×
copy
已复制链接
快去分享给好友吧!
我知道了
右上角分享
点击右上角分享
0
联系我们:info@booksci.cn Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。 Copyright © 2023 布克学术 All rights reserved.
京ICP备2023020795号-1
ghs 京公网安备 11010802042870号
Book学术文献互助
Book学术文献互助群
群 号:481959085
Book学术官方微信